Neogen Quarterly Balance Sheet
NASDAQ: NEOGHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Neogen financial position
As of Aug 31, 2026, Neogen reported total assets of $3.30 billion, down 2.2% from a year earlier against total liabilities of $1.22 billion. Shareholders' equity stood at $2.09 billion, or 63.2% of assets. The company held $172.0 million in cash and equivalents against $1.55 billion of debt, a net debt position of $1.38 billion.
The current ratio (current assets divided by current liabilities) was 3.90, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.74.
Summary generated from market data by MetaCap's automated system. Methodology
Neogen balance sheet (quarterly)
| Quarter (USD) | Q1 20272026-08-31 | Q4 20262026-05-31 | Q3 20262026-02-28 | Q2 20262025-11-30 | Q1 20262025-08-31 | Q4 20252025-05-31 | Q3 20252025-02-28 | Q2 20252024-11-30 | Q1 20242024-08-31 | Q4 20242024-05-31 | Q3 20242024-02-29 | Q2 20242023-11-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 172.00M | 185.50M | 159.90M | 145.34M | 138.88M | 129.00M | 127.70M | 140.23M | 120.48M | 170.61M | 161.44M | 205.76M |
| Short-Term Investments | — | — | — | — | — | 0 | 0 | 0 | 0 | 325.00K | 7.01M | 24.50M |
| Receivables | 136.20M | 146.80M | 137.10M | 132.00M | 138.46M | 153.40M | 160.07M | 164.09M | 167.64M | 173.00M | 173.59M | 150.50M |
| Inventory | 146.10M | 144.30M | 161.70M | 162.77M | 193.41M | 190.80M | 205.44M | 198.27M | 198.60M | 189.27M | 182.39M | 160.53M |
| Total Current Assets | 582.50M | 604.60M | 590.00M | 574.58M | 524.06M | 576.90M | 551.71M | 570.45M | 540.65M | 589.23M | 602.47M | 624.37M |
| Property, Plant & Equipment | 329.80M | 329.80M | 331.90M | 332.36M | 345.89M | 339.10M | 327.84M | 310.55M | 300.97M | 277.10M | 272.28M | 244.30M |
| Goodwill | 1.05B | 1.05B | 1.05B | 1.05B | 1.07B | 1.06B | 1.67B | 1.67B | 2.14B | 2.14B | 2.14B | 2.14B |
| Intangible Assets | 1.30B | 1.32B | 1.34B | 1.36B | 1.39B | 1.41B | 1.44B | 1.46B | 1.49B | 1.51B | 1.54B | 1.56B |
| Total Assets | 3.30B | 3.35B | 3.36B | 3.36B | 3.38B | 3.44B | 4.04B | 4.05B | 4.50B | 4.55B | 4.58B | 4.60B |
| Accounts Payable | 77.60M | 79.10M | 75.20M | 63.04M | 76.60M | 79.60M | 72.24M | 79.57M | 61.46M | 83.06M | 89.75M | 112.18M |
| Short-Term Debt | 780.00M | 0 | 800.00M | 800.00M | 800.00M | 19.30M | — | — | — | 2.45M | 2.52M | 2.57M |
| Total Current Liabilities | 149.50M | 158.20M | 150.60M | 147.05M | 146.21M | 174.00M | 141.20M | 151.19M | 122.69M | 154.32M | 157.84M | 176.61M |
| Long-Term Debt | 774.20M | 793.70M | 793.30M | 792.93M | 792.53M | 874.80M | 890.61M | 889.87M | 889.13M | 888.39M | 887.65M | 886.91M |
| Total Liabilities | 1.22B | 1.25B | 1.26B | 1.26B | 1.26B | 1.37B | 1.38B | 1.39B | 1.37B | 1.40B | 1.44B | 1.45B |
| Shareholders' Equity | 2.09B | 2.09B | 2.10B | 2.10B | 2.12B | 2.07B | 2.66B | 2.67B | 3.14B | 3.14B | 3.15B | 3.15B |
| Retained Earnings | -556.20M | -544.30M | -533.00M | -516.01M | -500.09M | -536.40M | 75.77M | 86.73M | 543.01M | 555.62M | 561.03M | 563.06M |
| Total Debt | 1.55B | 793.70M | 1.59B | 1.59B | 1.59B | 894.10M | 890.61M | 889.87M | 889.13M | 890.84M | 890.17M | 889.48M |
| Net Cash (Debt) | -1.38B | -608.20M | -1.43B | -1.45B | -1.45B | -765.10M | -762.90M | -749.64M | -768.65M | -719.90M | -721.73M | -659.22M |
| Shares Outstanding | 218.30M | 217.70M | 217.67M | 217.53M | 217.30M | 217.00M | 217.04M | 216.94M | 216.70M | 217.04M | 216.61M | 216.52M |
This table shows 12 quarterly periods of Neogen's balance sheet, from Q1 2027 back to Q2 2024, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow NEOG's reporting calendar. What is a balance sheet?